TESTOJACK Trademark

Trademark Overview


On Friday, November 15, 2024, a trademark application was filed for TESTOJACK with the United States Patent and Trademark Office. The USPTO has given the TESTOJACK trademark a serial number of 98856644. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Sunday, December 8, 2024. This trademark is owned by NOW HEALTH GROUP, INC.. The TESTOJACK trademark is filed in the Pharmaceutical Products category with the following description:

Dietary and nutritional supplements
testojack

General Information


Serial Number98856644
Word MarkTESTOJACK
Filing DateFriday, November 15, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateSunday, December 8, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesDietary and nutritional supplements

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, November 15, 2024
Primary Code005
First Use Anywhere DateTuesday, November 30, 2004
First Use In Commerce DateTuesday, November 30, 2004

Trademark Owner History


Party NameNOW HEALTH GROUP, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBLOOMINGDALE, IL 60108

Trademark Events


Event DateEvent Description
Friday, November 15, 2024NEW APPLICATION ENTERED
Friday, November 15, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, November 30, 2024ASSIGNED TO EXAMINER
Sunday, December 8, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, December 8, 2024NON-FINAL ACTION WRITTEN
Sunday, December 8, 2024NON-FINAL ACTION E-MAILED